The tissue matters
Human skin contains a cannabinoid-responsive signaling network. Facial skin deserves its own formulation strategy—not an assumption that it behaves like skin elsewhere on the body.
Professional CBD facial skincare · Since 2015
CBD, chosen
for the face.
At Color Up, facial skincare is built around high-purity CBD isolate, purposeful botanicals, and the full behavior of the finished formula—not the biggest number on a label.
A facial-specific formulation standard
Not every cannabinoid belongs everywhere.
Facial skin has its own barrier characteristics, sebaceous activity, environmental exposure, and reactivity. CBD and THC are not interchangeable, and body-care formulation does not automatically translate to the face.
The cannabinoid matters
CBD has low affinity for primary CB1 and CB2 binding sites and interacts through a broader set of pathways relevant to skin biology. That is why CBD is Color Up’s facial-care cannabinoid.
The formula matters
Concentration is one part of a finished formula. The vehicle, carriers, companion ingredients, application, and intended use all affect what a topical product does at the skin.
Precision over potency
More CBD doesn’t automatically mean better.
The milligram amount tells you how much CBD is present in the product. It does not, by itself, tell you how much will leave that vehicle, be deposited in the skin, or be available at the intended site.
In a 2022 human-skin study, increasing CBD from 5% to 10% did not significantly increase the amount absorbed into skin after 24 hours. In a 2024 human-skin study, a lower-concentration colloidal formulation outperformed a higher-concentration oil under one set of conditions, while doubling a gel from 1% to 2% did not significantly increase skin deposition under finite-dose conditions.
Those studies did not test Color Up products. They do support the formulation principle Color Up has operated from since the beginning: the number on a bottle is not the whole story.
“More is not always better—better is better.”We formulate for science, not trends.
5% vs. 10% CBD in human skin
A 2022 study found no significant difference in CBD absorbed into human skin from 5% versus 10% solutions after 24 hours.
Read on PubMedFormulation and delivery efficiency
A 2024 study found delivery depended strongly on formulation; a lower-concentration colloidal system could outperform a higher-concentration oil.
Read the full studyWhy CBD?
CBD is our gold standard for facial skincare.
Published research and Color Up’s long-term professional experience point in the same direction: choose the cannabinoid for the tissue, the delivery system, and the intended use.
What the research supports
Studies in human sebocytes and skin cells indicate that CBD can influence excessive lipid production under experimental conditions, inflammatory signaling, oxidative-stress pathways, and keratinocyte biology. Those are interesting formulation considerations—not a diagnosis or disease-treatment promise.
CBD’s dermatologic biology extends beyond a simplified “CBD receptor” story. Its pathways include TRP channels, PPARγ, adenosine signaling, and other signaling processes in addition to cannabinoid receptors.
What Color Up has observed
Across years of formulation work, professional treatments, and feedback from licensed skincare professionals, we found CBD to be the appropriate facial-care cannabinoid for our formulas.
Color Up does not use THC in facial skincare. This is a formulation standard informed by our practice; it is not a claim that topical THC universally causes reactivity or that published research has established such a rule.
For body care, the formulation conversation may be different. Color Up may use a broader cannabinoid profile in body-care products such as massage products, Butter Up, and salves when that formula and intended use support it. Facial skincare remains CBD-isolate focused.
Read the science
Primary research, plainly presented.
These studies provide context for our formulation philosophy. They do not test Color Up products or establish individual treatment outcomes.
CBD and sebocytes
Human sebocyte research on CBD’s sebostatic and anti-inflammatory activity.
Read on PubMedThe cutaneous ECS
Cannabinoid receptors and the endocannabinoid system in human skin.
Read on PubMedSkin biology and homeostasis
Review of cannabinoid signaling in skin biology and homeostasis.
Read on PubMedInflammatory signaling
CBD and inflammatory signaling in keratinocytes and fibroblasts.
Read on PubMedOxidative-stress pathways
CBD and oxidative stress in human skin cells.
Read on PubMedCBD and CB1 modulation
CBD as a negative allosteric modulator of the CB1 receptor.
Read in PMCCannabinoid pharmacology
Foundational review of cannabinoid pharmacology and CB1/CB2 activity.
Read in PMCThis page focuses on facial skincare and topical product education. Color Up does not offer ingestible products. For questions about a medical condition, medication, pregnancy, nursing, or a child, speak with a qualified healthcare professional.
Continue learning
Questions deserve a fuller answer.
Explore the foundational concepts behind CBD, inspect product documentation, or connect with the Color Up education library.
The endocannabinoid system
Start with the system that helps explain why cannabinoid formulation is more complex than a single ingredient claim.
Read the guideWhat is CBD isolate?
Understand the cannabinoid standard Color Up uses for its facial skincare formulas.
Explore CBD isolateLab tests and COAs
Open current lab tests, certificates of analysis, and product documentation to see how Color Up approaches transparency.
Explore lab tests & COAsThe scientific references on this page discuss laboratory, cell, skin-model, and formulation research. They do not establish that a cosmetic product diagnoses, treats, cures, or prevents any disease, and individual results vary.